Categories : Oncology
Product Packaging : 28 in HDPE
Product Composition : 100mg, 150mg
Olaparib tablets are advanced targeted oncology medicines classified as PARP inhibitors, primarily used in the treatment of ovarian, breast, pancreatic, and prostate cancers associated with BRCA mutations. The formulation works by blocking the PARP enzyme, preventing DNA repair in cancer cells and leading to their destruction, making it a key option in precision oncology.
In international pharmaceutical trade, Olaparib tablets exporter India and PARP inhibitor supplier India are highly searched by oncology distributors and specialty drug importers. Genliva Wellness LLP, Himatnagar, operates as a pharma exporter India precision oncology medicines partner, supplying innovative targeted therapies to global healthcare markets with consistent quality and regulatory compliance.
Send MessageOlaparib tablets are advanced targeted oncology medicines classified as PARP inhibitors, primarily used in the treatment of ovarian, breast, pancreatic, and prostate cancers associated with BRCA mutations. The formulation works by blocking the PARP enzyme, preventing DNA repair in cancer cells and leading to their destruction, making it a key option in precision oncology.
In international pharmaceutical trade, Olaparib tablets exporter India and PARP inhibitor supplier India are highly searched by oncology distributors and specialty drug importers. Genliva Wellness LLP, Himatnagar, operates as a pharma exporter India precision oncology medicines partner, supplying innovative targeted therapies to global healthcare markets with consistent quality and regulatory compliance.
